Lupin Limited has received the United States Food and Drug Administration approval for its generic version of Prucalopride tablets. These tablets are used for treating chronic idiopathic constipation. The approved strengths are 1 mg and 2 mg. This generic medicine is bioequivalent to Takeda Pharmaceuticals’ Motegrity tablets. Lupin will manufacture the product at its Goa facility in India.
Categories
Finance/Money
Lupin gets USFDA nod for generic chronic constipation treatment drug
